SEC Form D private-offering filing

Prince Biotech, Inc.

A new SEC Form D private-offering notice from Mason, OH, a $10,000,000 filer-stated offering target in Biotech. The source filing is one click away.

Prince Biotech, Inc. site↗ Verified via SEC Form D

Develops immune and regenerative medicine therapies based on Preimplantation Factor (PIF), a pregnancy derived molecule, through its subsidiary BioIncept.

Filed 2025-10-27Filed to raise $10,000,000HQ (as filed) Mason, OHSector Biotech Stage (inferred) EarlyCall status No reported sale
Source linked the Form D on EDGAR↗Website verified princebiotech.com↗Named in the filing 5 executives & directors

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.